genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
News
Cancer Cells May Have Achilles’ Heel in Cholesterol
News
Autism Severity Largely Linked to Hidden Part of the Human Genome
Artificial Intelligence
Artificial Intelligence Improves Ovarian Cancer Prognosis
News
CRISPR Toolbox Gains an Enhanced Cas12a for Genome Editing
Insights
Insights
Eyeing Epigenetics
Bioprocessing
Key Cell Culture Technology Trends
Bioprocessing
Sanofi Inks Bispecific Antibody Deal with Biomunex
Bioprocessing
Fujifilm to Build New U.K. Center of Excellence
Bioprocessing
SGS Expands Glasgow Facility’s Testing Capabilities
A-Lists
Insights
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
Posters
High-intensity UV LEDs for Point of Use Production of RNase-free Water
News
Cancer Cells May Have Achilles’ Heel in Cholesterol
Posters
High-throughput Gene Expression Analysis of 3D Airway Organoids
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Posters
High-intensity UV LEDs for Point of Use Production of RNase-free Water
Posters
High-throughput Gene Expression Analysis of 3D Airway Organoids
Webinars
Better by Design: Single-Cell Characterization for Enhanced Cell Therapies
Webinars
Biology by Design: Applying Gigabases of DNA to Bioengineering
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
T Cells
CAR T-Cells
CAR T-Cells
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
CAR T-Cells
Cell Therapy Manufacturing: The Supply Chain Challenge
CAR T-Cells
Identification of Sprouty 1 and Sprouty 2 Provide Basis for New Immunotherapies
CAR T-Cells
Regeneron to Invest $100M in bluebird bio as Companies Partner in Cancer Therapies
CAR T-Cells
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
CAR T-Cells
Amgen, MD Anderson Launch Two Cancer Collaborations
CAR T-Cells
Controllable “Swiss Army Knife” CAR T Cells Solve Key Efficacy and...
CAR T-Cells
MD Anderson, Berkeley Lights Launch Cancer Cell Therapy Company
CAR T-Cells
FDA Imposes Clinical Hold on Bellicum Lead Candidate BPX-501
CAR T-Cells
Celgene to Acquire Juno for $9B, Expanding CAR-T, TCR Presence
CAR T-Cells
Kite, Pfizer to Assess Yescarta-Utomilumab Combination in Lymphoma
CAR T-Cells
Novel Biomaterials Boost T-Cell Production
CAR T-Cells
Cancer Immunotherapy Channeled via Remote Control
CAR T-Cells
3D Bioscaffold Mimics Antigen-Presenting Cells for Improved T-Cell Expansion
CAR T-Cells
CAR-Engineered Blood Stem Cells Offer New Hope for Long-Term HIV Gene...
CAR T-Cells
VEGF-A Found Critical in Helping T Cells to Kill Tumors
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![SUPRA CAR-T offers several advantages over existing CAR-T therapy. [Cell]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr27_2018_Cell_ImprovingCarTTherapy2114263165-324x160.jpg "Controllable “Swiss Army Knife” CAR T Cells Solve Key Efficacy and Safety Issues")
![Regeneron Pharmaceuticals demonstrated its VelocImmune technology in a study published in 2015 in Proceedings of the National Academy of Sciences showing the rapid generation of fully human neutralizing antibodies against Middle East Respiratory Syndrome coronavirus (MERS-CoV) and development of a humanized mouse model for MERS-CoV infection (pictured). Regeneron will use VelocImmune and other VelociSuite platform technologies in a collaboration with bluebird bio to develop new immune cell therapies for cancer. [Source: PNAS]](https://www.genengnews.com/wp-content/uploads/2018/08/F7large2321726613-265x198.jpg "Regeneron to Invest $100M in bluebird bio as Companies Partner in Cancer Therapies")
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-265x198.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")